Mounjaro, Zepbound May Lower Risk of Eye Disease in People With Diabetes

Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of diabetic retinopathy.
Healthline Daily News
Labcorp
February 21, 2026
Mounjaro, Zepbound May Lower Risk of Eye Disease in People With Diabetes
 
READ ON
→
U.S. May Lose Measles-Free Status Amid Outbreaks in South Carolina, Other States
 
READ ON
→
8 Best Vitamins for Kids in 2026: Dietitians Weigh In
 
READ ON
→
FAQS about Genetic Risk for Hereditary ATTR-CM (hATTR-CM)
 
READ ON
→
MORE STORIES
 
 
 
Sponsored
Check Your Heart Health with Labcorp OnDemand
Gain deeper insights into your cardiovascular health. Use code HEALTHLINE for 10% off a Comprehensive Heart Health Test.
SHOP NOW  →
  Check Your Heart Health with Labcorp OnDemand
 
 
 
PRODUCT PICK
 
TODAY'S RESOURCE
 
What we're reading next
Everything You Need to Know to Get Healthy, Long Eyelashes
Types of Sleep Apnea
The Mind-Heart Connection
Biking for Weight Loss: 4 Effective Strategies to Try
FOLLOW US ON INSTAGRAM
@healthline
healthline
fb   tiktok   X   youtube   insta

Popular posts from this blog

🎧 How to Use Claude Code as a Second Brain

Mosseri’s AI bombshell

VidCon 2025: What’s Next for Creators, Brands & Platforms